KongAM, PozenA, AnastosK, KelvinEA, NashD. Non-HIV Comorbid conditions and polypharmacy among people living with HIV age 65 or older compared with HIV-negative individuals age 65 or older in the United States: A retrospective claims-based analysis. AIDS Patient Care STDs, 2019; 33:93–103.
2.
BrownTT, QaqishRB. Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: A meta-analytic review. AIDS, 2006; 20:2165–2174.
3.
CotterAG, SabinCA, SimelaneS, et al.Relative contribution of HIV infection, demographics and body mass index to bone mineral density. AIDS, 2014; 28:2051–2060.
4.
YinMT, ZhangCA, McMahonDJ, et al.Higher rates of bone loss in postmenopausal HIV-infected women: A longitudinal study. J Clin Endocrinol Metab, 2012; 97:554–562.
5.
GonciuleaA, WangR, AlthoffKN, et al.An increased rate of fracture occurs a decade earlier in HIV+ compared with HIV- men. AIDS, 2017; 31:1435–1443.
6.
ThompsonMA, HorbergMA, AgwuAL, et al.Primary care guidance for persons with human immunodeficiency virus: 2020 Update by the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis 2020 Nov 6; ciaal391. doi: 10.1093/cid/ciaa1391 [Epub ahead of print].
7.
HorbergMA, CertaJM, RubensteinKB, et al.Beyond the HIV care continuum and viral suppression: broadening the scope of quality metrics for total HIV patient care. AIDS Patient Care STDs, 2020; 34:461–469.
8.
BregigeonS, GalinierA, Zaegel-FaucherO, et al.Frailty in HIV infected people: A new risk factor for bone mineral density loss. AIDS, 2017; 31:1573–1577.
